Website News and Research

RSS

Majority of customers are satisfied with MediCare International, shows survey

A recent survey of users of international private healthcare insurer MediCare International has reported that 95% of those surveyed were either very satisfied or satisfied with their overall service experience.

14 Aug 2014

Researchers examine reason for patients being discharged from hospice care

About 1 in 5 Medicare patients is discharged from hospice care alive, whether due to patients' informed choice, a change in their condition, or inappropriate actions by the hospice to save on hospitalization costs related to terminal illness.

14 Aug 2014

Unresolved citizenship, immigration status threaten health law coverage for 310,000 people

The federal government has mailed notification to the people in three dozen states. These people have until Sept. 5 to present green cards, citizenship documents or other information to prove their eligibility for health insurance purchased through the online insurance marketplace.

14 Aug 2014

Insurance rate hikes could be issue in key states

Although rate hikes average 7.5 percent nationally for the individual health insurance market, consumers in politically key states such as Florida and North Carolina may see higher increases-- and insurers are partly blaming the administration's decision to allow consumers to hold onto their old policies.

14 Aug 2014

MRSA and antibiotic resistance is a major health threat

Antibiotic resistance continues at an alarming rate with the indiscriminate overuse of antibiotics given to humans and animals.

13 Aug 2014

Novogen declares shareholder meeting results

Australia-US biotechnology company, Novogen Ltd., an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia.

13 Aug 2014

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS).

13 Aug 2014

Andrews Institute performs free injury evaluations for student athletes

Student athletes will soon have access to free injury evaluations by an orthopaedic physician on Saturdays at the Andrews Institute for Orthopaedics & Sports Medicine.

13 Aug 2014

HealthCare.gov fixer takes top spot of new 'U.S. Digital Service'

The White House says it wants to apply the approach that was used to resuscitate the federal online insurance marketplace after its disastrous launch to the government's other troubled websites and computer systems.

13 Aug 2014

Tackling rising healthcare costs: an interview with Professor Graeme Currie, Warwick Business School

I think the main reason involves the impact of an aging population, some of whom age healthily, but many of whom, unhealthily, particularly those from poorer sectors of society.

12 Aug 2014

Wolters Kluwer Health's new edition addresses full spectrum of modern primary care

Wolters Kluwer Health, a leading global provider of information and point-of-care solutions for the healthcare industry and students of medicine, today introduced the seventh edition of Primary Care Medicine: Office Evaluation and Management of the Adult Patient, the seminal information resource for office-based adult patient care.

12 Aug 2014

More intensive types of approaches tend to be more effective in treating severely obese teenagers

Nearly 6% of all children and teens in the U.S. are severely obese, and the prevalence of severe obesity is increasing faster than that of moderate obesity or overweight.

12 Aug 2014

Exchange news: Oracle sues Ore. for $23M; Mass. sticks with state-run website

Oracle Corp., the primary developer behind Oregon's dysfunctional health insurance website, sued Cover Oregon and accused Gov. John Kitzhaber of conducting a "smear campaign" against the company. Meanwhile, Massachusetts officials decided to replace that state's failed exchange with another from a private company, rather than shifting to the federal marketplace.

12 Aug 2014

BioSpecifics Technologies total revenue for second quarter decreases by 19%

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the second quarter ended June 30, 2014 and provided a corporate update.

12 Aug 2014

Novogen receives funding support to commence studies in muscular dystrophy

The Australian biotechnology company, Novogen Limited today announced receipt of funding from the FSHD Global Research Foundation as part of the Company’s efforts to find effective treatments for a range of musculo-degenerative diseases including facioscapulohumeral dystrophy (FSHD).

11 Aug 2014

Women with problem transvaginal mesh surgery must hurry to file claims

Women with problem transvaginal mesh surgery must hurry to file their claims, according to a major public information website for mesh victims, or risk not participating in current billion-dollar court settlements.

8 Aug 2014

Vitro toxicity testing an alternative to predict adverse health effects of drugs

In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of drugs and personal care products and the health consequences of environmental exposures.

8 Aug 2014

Advion introduces high performance liquid chromatography to complement its CMS

Advion, Inc., a leading systems and consumables developer for the life sciences industry, introduces an affordable high performance liquid chromatography system to complement its line of expression compact mass spectrometers (CMS). Introduced in 2012, the CMS has been met with glowing reviews from the global synthetic organic chemistry market. With hundreds of CMS purchased and installed, this latest introduction offers a complete solution for those needing separation capabilities at an affordable price.

From Advion 7 Aug 2014

Celsion announces financial results for second quarter ended 2014

Celsion Corporation, an oncology drug development company, today announced financial results for the second quarter ended June 30, 2014.

7 Aug 2014

Advion releases Direct Analysis Probe for the compact mass spectrometer (CMS) product line

Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.

From Advion 7 Aug 2014

Website News and Research

Majority of customers are satisfied with MediCare International, shows survey

Researchers examine reason for patients being discharged from hospice care

Unresolved citizenship, immigration status threaten health law coverage for 310,000 people

Insurance rate hikes could be issue in key states

MRSA and antibiotic resistance is a major health threat

Novogen declares shareholder meeting results

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Andrews Institute performs free injury evaluations for student athletes

HealthCare.gov fixer takes top spot of new 'U.S. Digital Service'

Tackling rising healthcare costs: an interview with Professor Graeme Currie, Warwick Business School

Wolters Kluwer Health's new edition addresses full spectrum of modern primary care

More intensive types of approaches tend to be more effective in treating severely obese teenagers

Exchange news: Oracle sues Ore. for $23M; Mass. sticks with state-run website

BioSpecifics Technologies total revenue for second quarter decreases by 19%

Novogen receives funding support to commence studies in muscular dystrophy

Women with problem transvaginal mesh surgery must hurry to file claims

Vitro toxicity testing an alternative to predict adverse health effects of drugs

Advion introduces high performance liquid chromatography to complement its CMS

Celsion announces financial results for second quarter ended 2014

Advion releases Direct Analysis Probe for the compact mass spectrometer (CMS) product line

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News